Acadia Pharma (ACAD)
$15.90
0.72 (4.53%)
GILD Stock: What Investors Really Want to See From Q3
Gilead Science's Q3 numbers aren't as important to GILD stock compared to what it does to solidify the future.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$16.32
Market Cap
2.77B
PE Ratio
11.68
EPS
1.3612
Volume (Avg. Vol.)
1.96M
Day's Range
$16.18 - $16.73
52-Week Range
$14.15 - $20.68
Dividend & Yield
N/A (N/A)